We are live on
!
Find out more
AI
Alphabet Inc Portfolio holdings
AUM
$4.02B
1-Year Est. Return
215.74%
This Fund
S&P 500
This Quarter
Est. Return
-1.79%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.19B
AUM Growth
+$576M
(+94%)
Cap. Flow
+$655M
Cap. Flow
% of AUM
55.04%
Top 10 Holdings %
Top 10 Hldgs %
96.06%
Holding
18
New
7
Increased
–
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$523M |
| 2 |
DOCU
DocuSign
DOCU
|
+$73.8M |
| 3 |
Dianthus Therapeutics
DNTH
|
+$47.1M |
| 4 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
+$24M |
| 5 |
AUTL
Autolus Therapeutics
AUTL
|
+$18.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
+$45.4M |
| 2 |
CLDR
Cloudera, Inc.
CLDR
|
+$3.14M |
| 3 |
Denali Therapeutics
DNLI
|
+$570K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 44.35% |
| 2 | Healthcare | 16.6% |
| 3 | Technology | 16.04% |
| 4 | Communication Services | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
JD.com
JD
$40.8B
| $528M | 44.35% |
+13,553,474
| New | +$523M |
|
|
ARRS
2
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $237M | 19.93% |
9,703,500
| – | – |
|
3
Zscaler
ZS
$23B
| $99.7M | 8.37% |
2,788,560
| – | – |
|
|
DOCU
4
DocuSign
DOCU
$9.63B
| $77.4M | 6.5% |
+1,461,106
| New | +$73.8M |
|
5
Arcus Biosciences
RCUS
$3.57B
| $61.8M | 5.19% |
5,049,786
| – | – |
|
|
6
Dianthus Therapeutics
DNTH
$5.68B
| $45.1M | 3.79% |
+208,696
| New | +$47.1M |
|
7
Snap
SNAP
$7.32B
| $34.3M | 2.88% |
2,618,548
| – | – |
|
|
FTSV
8
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $24.7M | 2.08% |
+1,545,966
| New | +$24M |
|
|
AUTL
9
Autolus Therapeutics
AUTL
$386M
| $19.1M | 1.61% |
+714,072
| New | +$18.9M |
|
10
Spero Therapeutics
SPRO
$68.9M
| $16.3M | 1.37% |
1,112,473
| – | – |
|
|
EVLO
11
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $12.5M | 1.05% |
+53,025
| New | +$15.5M |
|
|
CLDR
12
DELISTED
Cloudera, Inc.
CLDR
| $11.7M | 0.98% |
855,420
-206,000
| -19% | -$3.14M |
|
13
X4 Pharmaceuticals
XFOR
$363M
| $9.83M | 0.83% |
2,508
| – | – |
|
|
14
Denali Therapeutics
DNLI
$3.67B
| $8.18M | 0.69% |
536,411
-30,255
| -5% | -$570K |
|
|
PS
15
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $2.48M | 0.21% |
+101,442
| New | +$2.44M |
|
|
XYZ
16
Block Inc
XYZ
$45.9B
| $1.81M | 0.15% |
29,400
| – | – |
|
17
Dropbox
DBX
$6.81B
| $423K | 0.04% |
13,033
| – | – |
|
|
ARMO
18
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| – | – |
-1,214,700
| Closed | -$45.4M |
|
Similar funds
JSW
BWA
MAM
GCM
USCWA
ICP
CA
MGP
Alphabet Inc's Q2 2018 Portfolio in Review
As of Q2 2018, Alphabet Inc held 18 positions worth $1.19B, up 94% from $615M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Alphabet Inc deployed $655M of net new capital in Q2 2018, opening 7 new positions. Its largest new stake was JD.com: 13,553,474 shares worth $528M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 44% of assets, followed by Healthcare and Technology.
On the sell side, the largest reduction was Cloudera, Inc., an estimated $3.14M trimmed.
- Alphabet Inc's largest Q2 2018 buy was JD.com: 13,553,474 shares worth $528M.
- Alphabet Inc's biggest Q2 2018 reduction was Cloudera, Inc., cutting an estimated $3.14M.
- Alphabet Inc fully exited ARMO BioSciences, Inc. Common Stock in Q2 2018, selling an estimated $45.4M.
- Alphabet Inc's ten largest holdings make up 96% of its $1.19B portfolio in Q2 2018.
- Alphabet Inc opened 7 new positions and closed 1 in Q2 2018.
- Alphabet Inc's portfolio value rose 94% quarter-over-quarter to $1.19B.
Based on Alphabet Inc's 13F filing for Q2 2018, filed 15 Nov 2022.